New York State Common Retirement Fund Biovie Inc. Transaction History

New York State Common Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$0.4 - $0.56 $6,880 - $9,632	-17,200 Reduced 99.8%	35 $0
Q3 2023 Nov 07, 2023	BUY	$2.75 - $5.17 $96 - $180	35 Added 0.2%	17,235 $59,000
Q2 2023 Aug 07, 2023	BUY	$4.09 - $8.29 $70,348 - $142,587	17,200 New	17,200 $74,000

4.73M

17.2K

27K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.